CARNITOR

This brand name is authorized in Canada, Estonia, Hong Kong, United Kingdom, United States

Active ingredients

The drug CARNITOR contains one active pharmaceutical ingredient (API):

1 L-carnitine UNII 0G389FZZ9M - LEVOCARNITINE

Levocarnitine as a factor is necessary in the transport of long-chain fatty acids into the mitochondria-facilitating the oxidation of fatty acids rather than their incorporation into triglycerides. Read about L-carnitine

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
CARNITOR Tablet / Oral solution	FDA, National Drug Code (US)	MPI, US: SPL/Old

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
A16AA01	Levocarnitine	A Alimentary tract and metabolism → A16 Other alimentary tract and metabolism products → A16A Other alimentary tract and metabolism products → A16AA Amino acids and derivatives
Discover more medicines within A16AA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 02144328, 02144336, 02144344
Country: EE	Ravimiamet	Identifier(s): 1746176
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 172879, 381247, 45347, 91536
Country: HK	Department of Health Drug Office	Identifier(s): 39342, 41015
Country: US	FDA, National Drug Code	Identifier(s): 54482-144, 54482-145, 54482-147, 54482-148